CAPS2 (Calcyphosine 2) (average methylation 26%, p = 0.005) and GLIPR1L2 (GLI pathogenesis-related 1) (average methylation 30%, p = 0.008), both were previously discussed in the group due to hypomethylation in PD-L1 high-expressing carcinomas. This evidence concerns the gene GLIPR1L2 and carcinoma.